MXPA04005225A - Aril-cicloalcanos substituidos, composiciones que los contienen y su utilizacion. - Google Patents

Aril-cicloalcanos substituidos, composiciones que los contienen y su utilizacion.

Info

Publication number
MXPA04005225A
MXPA04005225A MXPA04005225A MXPA04005225A MXPA04005225A MX PA04005225 A MXPA04005225 A MX PA04005225A MX PA04005225 A MXPA04005225 A MX PA04005225A MX PA04005225 A MXPA04005225 A MX PA04005225A MX PA04005225 A MXPA04005225 A MX PA04005225A
Authority
MX
Mexico
Prior art keywords
anticancer agents
cycloalkanes
substituted aryl
group
substituted phenyl
Prior art date
Application number
MXPA04005225A
Other languages
English (en)
Inventor
Caulfield Thomas
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MXPA04005225A publication Critical patent/MXPA04005225A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Aril-cicloalcanos substituidos, composiciones que los contienen y utilizacion. La presente invencion se refiere, principalmente, a los aril-cicloalcanos substituidos que tienen una actividad terapeutica, utilizables en particular en oncologia.
MXPA04005225A 2001-12-05 2002-12-03 Aril-cicloalcanos substituidos, composiciones que los contienen y su utilizacion. MXPA04005225A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0115740A FR2833004B1 (fr) 2001-12-05 2001-12-05 Aryl-cycloalcaines substitues, compositions les contenant et utilisation
PCT/FR2002/004142 WO2003048096A1 (fr) 2001-12-05 2002-12-03 Aryl-cycloalcanes substitues et leur utilisation comme agents anticancereux

Publications (1)

Publication Number Publication Date
MXPA04005225A true MXPA04005225A (es) 2004-10-11

Family

ID=8870151

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005225A MXPA04005225A (es) 2001-12-05 2002-12-03 Aril-cicloalcanos substituidos, composiciones que los contienen y su utilizacion.

Country Status (16)

Country Link
US (1) US6887904B2 (es)
EP (1) EP1453783B1 (es)
JP (1) JP2005511676A (es)
AR (1) AR037478A1 (es)
AT (1) ATE341531T1 (es)
AU (1) AU2002365643A1 (es)
CA (1) CA2469349A1 (es)
DE (1) DE60215217T2 (es)
DK (1) DK1453783T3 (es)
ES (1) ES2272816T3 (es)
FR (1) FR2833004B1 (es)
MX (1) MXPA04005225A (es)
PT (1) PT1453783E (es)
SI (1) SI1453783T1 (es)
TW (1) TW200300756A (es)
WO (1) WO2003048096A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037810A2 (fr) * 2003-10-17 2005-04-28 Sanofi-Aventis Derives de cyclopropylmethanones, leur preparation et leur utilisation en therapeutique
FR2861072B1 (fr) * 2003-10-17 2006-03-31 Sanofi Synthelabo Derives de cyclopropylmethanones, leur preparation et leur utilisation en therapeutique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1526708A (fr) * 1966-06-13 1968-05-24 Upjohn Co 1.3-amino-alcools, leurs intermédiaires et dérivés et leur procédé de préparation
FR1534252A (fr) * 1966-08-15 1968-07-26 Upjohn Co Nouvelles amines allyliques et procédé de préparation
US3506670A (en) * 1966-09-26 1970-04-14 Upjohn Co 2-hetero-amino-alpha,alpha-diaryl-cycloalkone-methanols and esters thereof
DE1935458A1 (de) * 1969-07-12 1971-01-14 Cassella Farbwerke Mainkur Ag Basisch substituierte Cyclohexyl- und Norbornyl-ketone
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives

Also Published As

Publication number Publication date
FR2833004B1 (fr) 2004-12-10
EP1453783B1 (fr) 2006-10-04
TW200300756A (en) 2003-06-16
CA2469349A1 (fr) 2003-06-12
PT1453783E (pt) 2007-01-31
AR037478A1 (es) 2004-11-10
US20030149072A1 (en) 2003-08-07
US6887904B2 (en) 2005-05-03
FR2833004A1 (fr) 2003-06-06
DE60215217D1 (de) 2006-11-16
JP2005511676A (ja) 2005-04-28
DK1453783T3 (da) 2007-01-29
AU2002365643A1 (en) 2003-06-17
ES2272816T3 (es) 2007-05-01
WO2003048096A1 (fr) 2003-06-12
ATE341531T1 (de) 2006-10-15
EP1453783A1 (fr) 2004-09-08
SI1453783T1 (sl) 2007-02-28
DE60215217T2 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
PT1070056E (pt) Inibidores de pde iii/iv a base de ftalazinona
TW200724033A (en) Anthranilamide arthropodicide treatment
DE60214591D1 (en) Pyrazolpyrimidinfungizide
GB0128996D0 (en) Organic compounds
CY1114554T1 (el) Ινδαζολια, βενζοτριαζολια και ν-αναλογα αυτων ως αναστολεις p38 κινασης
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
HUP0303436A2 (hu) Diaril-peptidek mint a hepatitis C vírus NS3-szerin proteáz inhibitorai, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HK1096549A1 (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors
DK0892780T3 (da) m-Amidinophenylanaloger som faktor Xa-inhibitorer
DE60007095T2 (de) Calanolide zur hemmung von btk
MXPA03006224A (es) Inhibidores de cruzipaina y otras proteasas de cisteina.
SE0303541D0 (sv) New compounds
SE9704543D0 (sv) New compounds
SE0101038D0 (sv) Novel compounds
DE50310579D1 (de) Furancarboxamide
UA83266C2 (en) Oxazole derivatives of tetracyclines
IT1300055B1 (it) Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici
DE60202669D1 (de) 6-phenylbenzonaphthyidine
RS20060206A (en) Aminopyridine-derivatives as inducible no-synthase inhibitors
MXPA04005225A (es) Aril-cicloalcanos substituidos, composiciones que los contienen y su utilizacion.
ATE495216T1 (de) Azeotropartige zusammensetzungen, die hexafluorpropylendimer enthalten, und verwendung davon
IT1317049B1 (it) Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv.
GB0103045D0 (en) Organic Compounds
RS20060196A (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors
TR200103240T2 (tr) Endoparazit öldürücü bileşimler.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal